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Abstract 
Purpose: To present a case of spontaneous aortic rupture in the course of mantle cell 
lymphoma and successful management with endovascular repair.  
Case Report: A 69-year-old woman presented with a cervical mass. The patient was found to 
have stage IIIA and Mantle Cell Lymphoma International Prognostic Index (MIPI) 4. She was 
placed in an intermediate-risk group. The patient received an initial cycle of systemic 
chemotherapy consisting of rituximab, anthracycline, vincristine and methyl prednisolone. 
During follow-up, she developed abdominal aortic rupture secondary to intramural 
hematoma which was successfully managed with endovascular exclusion.  
Conclusion: Hemodynamic changes can be seen during the course of lymphoma subsequent 
to systemic chemotherapy. These changes might be related to the spontaneous rupture of 
the main vessels. Endovascular repair may be a more appropriate treatment option than 
open surgery, especially in a patient with multiple comorbidities. 
 
Introduction 
Potential causes of aortic rupture are aneurysm, trauma and plaque rupture. 
Aneurysmal rupture during the course of systemic chemotherapy is an unusual and 
serious complication which is difficult to manage, especially in a patient whose health is 
compromised because of cancer and comorbid conditions. Specific therapeutic 
modalities have to be coordinated. One of the novel developments in interventional  
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radiology practice is endoluminal aortic stent grafting in the management of aortic 
aneurysm including aneurysmal rupture. The first encouraging experiences were 
published by Parodi et al. in 1991 [1]. Therein, the authors report a case with 
abdominal aortic rupture during the course of systemic chemotherapy and successful 
treatment with endovascular stent grafting in an urgent care setting. 
Case Report 
A 69-year-old woman presented with a cervical mass. She had been evaluated at an independent 
medical center and a cervical excisional biopsy had been performed. The patient was referred to our 
Medical Oncology Department with a pathology report. The patient had a history of mild hypertension 
with no need for medication. She had no history of weight loss, night fever or excessive sweating. Her 
physical examination was unremarkable except for cervical lymphadenopathy and obesity. 
Histopathological discussion of the biopsy revealed a diagnosis of mantle cell lymphoma. The patient 
was staged with PET-CT, endoscopic examination of the gastrointestinal system and bone marrow 
aspiration/biopsy. PET-CT showed multiple hypermetabolic foci at the cervical, mediastinal and 
retroperitoneal regions. The patient was staged as IIIA. MIPI (Mantle Cell Lymphoma International 
Prognostic Index) of the patient was 4, so she was placed in the intermediate-risk group. The 
treatment plan consisted of 6 cycles of R-CHOP regimen. Two days after the first cycle of systemic 
chemotherapy, syncope occurred, blood pressure was 70/50 mm Hg, and her hematocrit level was 
27%; the other parts of the complete blood count were normal, as were the results of other laboratory 
tests, including serum electrolytes and tests for renal and liver function. Cardiological and surgical 
evaluations were normal. 
The patient was transferred to the Intensive Care Unit. Over the next 2 days, her hematocrit values 
progressively decreased and 6 units of packed red blood cells were transfused. Vital signs remained 
normal during this period. Thoracic and abdominal CT scans were performed, revealing a huge 
intramural hematoma and a retroperitoneal hematoma (fig. 1). The retroperitoneal hematoma was 
secondary to the intramural hematoma. Her aorta did not seem aneurysmatic. Cardiovascular Surgery 
and the Interventional Radiology Unit consulted on the patient. Due to comorbid conditions, an open 
surgical procedure was considered to have high preoperative and postoperative mortality; thus the 
patient was transferred to the Interventional Radiology Unit. A percutaneous approach was used from 
the right and left common femoral arteries. Diagnostic angiography revealed that the distal aorta had 
minimal aneurysmatic dilatation which was very mild at 30 mm in diameter (fig. 2a). A 28-mm stent 
graft (Medtronic, USA) was placed into the aorta, and then the contralateral leg was placed. A check 
angiogram showed excellent positioning of the stent graft with no leak (fig. 2b). The patient’s 
hemoglobin level stabilized immediately after the stent-graft placement. 
Discussion 
The most frequent etiology of aortic rupture is aneurysm. Risk of rupture of an aortic 
aneurysm increases with increased diameter of the aorta. Currently, a diameter more 
than 55 mm is the indication for treatment with surgical or endovascular means. There 
are other potential causes such as trauma and plaque rupture. Nontraumatic, 
noninfectious rupture of the nonaneurysmal aorta is a very rare condition and the most 
frequent cause is penetrating atherosclerotic ulcer [2]. Abdominal aortic aneurysms 
(AAA) are common and generally asymptomatic unless rupture occurs. A 3–4-cm AAA 
has a 1–2% risk of rupture over 5 years [3]. Aneurysms in oncologic cases are mostly 
seen with colorectal carcinomas and usually located in the abdominal aorta. 
Aneurysmal and nonaneurysmal rupture of the aorta in oncologic cases is a very rare 
condition and mostly seen in patients who have tumors with periaortic localization and 
concomitant aneurysmal dilatation [4]. For primary aortic tumors, rupture has been  
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described only in a single case of leiomyosarcoma of the thoracic aorta [5]. Ehata et al. 
[6] reported a case of ruptured AAA repair in which a pheochromocytoma was 
diagnosed postoperatively by CT scan. Thompson et al. [7] also reported a case in 
which a pheochromocytoma was found using metaiodobenzylguanidine imaging after a 
repaired AAA began leaking. Moreover, 4 cases of dissecting thoracic aneurysms 
associated with pheochromocytoma have been described [6]. Spontaneous rupture of 
the nonaneurysmal aorta has been reported with tumor infiltration in 
neurofibromatosis [8]. All reported cases of primary malignant lymphoma invading the 
aorta were associated with symptomatic or ruptured aortic aneurysms. Aortoiliac 
fistula was found in 1 case and endovascular repair was successfully performed [9]. 
Penetrating ulcerated plaque and hemodynamic changes such as hypertension are 
the most common causes of aneurysmal rupture of the aorta. Chemotherapy is a stress 
factor for hemodynamic parameters, but the patient presented here received her 
systemic chemotherapy in the oncology ward due to the risk of probable tumor lysis 
syndrome. During in-ward follow-up, no abnormalities were detected by means of 
physical examination, vital signs and laboratory results. An abdominal CT scan was 
performed as part of the initial staging, and radiological evaluation showed no 
abnormality in the abdominal aorta. A repeat CT scan at the time of diagnosis of 
rupture did not show an aneurysmal aorta but a big intramural hematoma. Diagnostic 
angiography at the beginning of endovascular intervention showed a very mild 
dilatation of the distal abdominal aorta. 
At this point, the patient could be managed by either open surgery or endovascular 
stent grafting. Endovascular stent grafting has been shown to reduce procedure-related 
and early morbidity and mortality in a large prospective randomized trial [10]. Open 
surgery had the disadvantages of bleeding and infections due to cytopenia and may be 
hazardous because of poor conditional status and comorbid conditions of the patient. 
So we decided on endovascular stent grafting. 
Endovascular repair provides a valuable alternative in the acute setting of 
aneurysmal rupture and should be an established treatment option, especially in 
patients with several comorbid conditions. 
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Fig. 1. Contrast-enhanced CT image reveals significant leak from the aorta (arrow). There is a 
crescent-shaped hematoma in the aortic wall causing the rupture, and a more significant hematoma 
in the retroperitoneum. 
 
 
 
Fig. 2. a Aortogram before stent-graft placement reveals than the aorta is otherwise normal in size. 
There is a mild widening of the aorta on its left distal side. A leak is not visible on the aortogram. 
b Aortogram after stent-graft placement. The stent graft seals the whole infrarenal aorta excluding the 
rupture point. 
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